Journal article

The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction

Denis A Evseenko, Padma Murthi, James W Paxton, Glen Reid, B Starling Emerald, KM Mohankumar, Peter E Lobie, Shaun P Brennecke, Bill Kalionis, JA Keelan

The FASEB Journal | Wiley | Published : 2007

Abstract

ABSTRACT The efflux pump ATP binding cassette superfamily member G2 (ABCG2)/breast cancer resistance protein (BCRP) is highly expressed in human placenta. We have investigated the role of BCRP in the protection of the human placental trophoblasts from apoptosis and its expression in idiopathic fetal growth restriction, a condition associated with abnormal pla‐cental apoptosis. Inhibition of BCRP activity with the selective inhibitor Ko143 augmented cytokine (tumor necrosis factor‐α/interferon‐γ)‐induced apoptosis and phosphatidylserine externalization in primary tropho‐blast and trophoblast‐like BeWo cells. Silencing of BCRP expression in BeWo cells sig..

View full abstract

University of Melbourne Researchers